Tag #Weight Loss

repubblica.it
🌐 85% Global Worthiness
News related image

Eli Lilly's Oral Semaglutide Shows Promise, Poised to Disrupt Weight-Loss Market

Eli Lilly's oral semaglutide, orforglipron, shows promising results with 14.7% average weight loss in phase two trials, prompting a $550 million revenue projection and expected launch next year, intensifying competition in the $25 billion global obesity drug market.

Progress

48% Bias Score

Good Health and Well-being
theguardian.com
🌐 85% Global Worthiness
News related image

Wegovy Approved for Heart Disease Treatment in Australia

Australia's TGA approved Wegovy (semaglutide) in December 2024 for treating cardiovascular disease in overweight and obese adults, reducing heart attack/stroke risk by 20% in a 17,604-person Select trial, but PBS listing remains undecided due to cost.

Progress

36% Bias Score

Good Health and Well-being
theguardian.com
🌐 75% Global Worthiness
News related image

UK Insurer Vitality Offers Discounted Weight Loss Medication

Vitality, the UK's third-largest health insurer, is offering its 1.9 million members discounts of up to 20% on anti-obesity medications like Wegovy and Mounjaro, based on BMI and health conditions, to combat the £6.5 billion annual cost of obesity to the NHS.

Progress

40% Bias Score

Good Health and Well-being
bbc.com
🌐 65% Global Worthiness
News related image

Afghan Man Loses 125kg to Attend University

A 216kg Afghan man, Powerullah, lost 125kg in 10 months through a strict diet and intense exercise regime to attend university, overcoming health issues, social stigma, and mobility challenges.

Progress

36% Bias Score

Good Health and Well-being
dw.com
🌐 75% Global Worthiness
News related image

GLP-1 RA Drugs Show Promise, but Limitations Remain

A study of 1.2 million medical records found that GLP-1 RA drugs, such as Ozempic and Wegovy, may reduce the risk of several health issues, including substance use disorders, psychiatric disorders, and dementia, by 8-18%, but also carry risks of nausea, vomiting, and pancreatic or kidney complicatio...

Progress

44% Bias Score

Good Health and Well-being
dw.com
🌐 75% Global Worthiness
News related image

GLP-1RA Drugs Show Potential Link to Reduced Risk of Mental Health and Cognitive Conditions

A study of over 1.2 million veterans' medical records suggests a possible link between GLP-1 receptor agonist drugs, such as Ozempic and Wegovy, and a reduced risk of various mental health conditions, including suicidal thoughts, schizophrenia, dementia, and Alzheimer's disease, although further res...

Progress

44% Bias Score

Good Health and Well-being
bbc.com
🌐 75% Global Worthiness
News related image

Avoiding Glucose Spikes for Weight Loss: A Dietary Strategy

Avoiding rapid spikes in blood glucose, achieved by combining carbohydrates with fiber and protein, prevents excess sugar from being stored as fat, aiding weight loss and reducing long-term health risks like hypertension.

Progress

44% Bias Score

Good Health and Well-being
forbes.com
🌐 85% Global Worthiness
News related image

GLP-1 Drugs: Reshaping Beauty Standards and Social Status

The increasing availability of GLP-1 weight-loss drugs is disrupting traditional beauty standards, potentially diminishing the status associated with thinness and prompting the affluent to seek new markers of distinction.

Progress

52% Bias Score

Reduced Inequality
dw.com
🌐 75% Global Worthiness
News related image

Ozempic and Wegovy May Reduce Risk of Multiple Diseases: Large-Scale Study

A study of 1.2 million veterans' health records suggests that Ozempic and Wegovy, GLP-1 receptor agonists, may reduce risks of schizophrenia, Alzheimer's, and substance abuse, although further research is needed due to the study's limitations.

Progress

52% Bias Score

Good Health and Well-being
dailymail.co.uk
🌐 85% Global Worthiness
News related image

Fat Cell Memory Explains Weight Regain After Dieting

A Nature study reveals that fat cells 'remember' being fat, making weight loss difficult; 90% of dieters regain weight due to epigenetic changes in fat cells that persist even after weight loss, highlighting the need for long-term lifestyle changes for sustainable weight management.

Progress

40% Bias Score

Good Health and Well-being
dw.com
🌐 75% Global Worthiness
News related image

Diabetes Drugs Linked to Reduced Risk of Mental Health Issues

A study of 1.2 million veterans' medical records found that the diabetes and weight-loss drugs Ozempic and Wegovy (GLP-1 receptor agonists) may be linked to a reduced risk of various mental health issues, including alcohol and substance use disorders, suicidal thoughts, schizophrenia, dementia, and ...

Progress

24% Bias Score

Good Health and Well-being
nos.nl
🌐 85% Global Worthiness
News related image

Bariatric Surgery: A Last Resort for Severely Obese Children in the Netherlands

A scientific study in the Netherlands provides bariatric surgery to six obese children (13+) as a last resort after failed lifestyle interventions, addressing the rising rates of childhood obesity (12% overweight, 4.1% severely obese among 4-17 year olds) and its severe health consequences.

Progress

48% Bias Score

Good Health and Well-being